Suchergebnisse - (Subject:"Comment")

PubPharm (4.332)

1

Resistance Mechanisms in ROS1-Positive Lung Cancer : New Insight into a Rare but Clinically Important Entity

enthalten in: Clinical chemistry | 2024

von von Itzstein, M. | Gerber, D.

CommentOn: Clin Chem. 2024 Apr 3;70(4):629-641. - PMID 38416709

2

"New Targets in Non-Small-Cell Lung Cancer"-RET, HER2, and KRAS

enthalten in: American journal of respiratory and critical care medicine | 2024

von Halani, V. | Sharayah, A. | Beck, B. | +1

CommentOn: N Engl J Med. 2021 Jun 24;384(25):2371-2381. - PMID 34096690

3

Risk/benefit of BTK/venetoclax combos : the context matters!

enthalten in: Blood | 2024

von Seymour, J.

CommentOn: Blood. 2024 Feb 15;143(7):582-591. - PMID 37971194

4

VTE with Amivantamab plus Chemotherapy in NSCLC

enthalten in: The New England journal of medicine | 2024

von Moik, F. | Riedl, J. | Ay, C.

CommentOn: N Engl J Med. 2023 Nov 30;389(22):2039-2051. - PMID 37870976

5

VTE with Amivantamab plus Chemotherapy in NSCLC. Reply

enthalten in: The New England journal of medicine | 2024

von Zhou, C. | Agrawal, T. | Girard, N.

CommentOn: N Engl J Med. 2023 Nov 30;389(22):2039-2051. - PMID 37870976

6

Osimertinib with Chemotherapy in EGFR-Mutated NSCLC. Reply

enthalten in: The New England journal of medicine | 2024

von Planchard, D. | Jänne, P. | Kobayashi, K.

CommentOn: N Engl J Med. 2023 Nov 23;389(21):1935-1948. - PMID 37937763

7

Osimertinib with Chemotherapy in EGFR-Mutated NSCLC

enthalten in: The New England journal of medicine | 2024

von van Waalwijk van Doorn-Khosrovani, S. | Badrising, S. | Burgers, S.

CommentOn: N Engl J Med. 2023 Nov 23;389(21):1935-1948. - PMID 37937763

8

Incorporating Research Burden and Utility Considerations as Limiting Factors in a Framework for Returning IRR

enthalten in: The American journal of bioethics : AJOB | 2024

von Connor, C. | Berkman, B.

CommentOn: Am J Bioeth. 2024 Feb;24(2):69-90. - PMID 37155651

9

Comparison of subretinal aflibercept vs ranibizumab vs bevacizumab in the context of PPV, pneumatic displacement with subretinal air and subretinal tPA in naïve submacular haemorrhage secondary to nAMD. "The Submarine Study"

enthalten in: Eye (London, England) | 2024

von Iglicki, M. | Khoury, M. | Donato, L. | +3

CommentOn: Eye (Lond). 2023 Jun;37(8):1659-1664. - PMID 36038720

10

Selpercatinib or Chemotherapy in RET Fusion-Positive NSCLC

enthalten in: The New England journal of medicine | 2024

von Dingemans, A. | Smit, E. | Hendriks, L.

CommentOn: N Engl J Med. 2023 Nov 16;389(20):1839-1850. - PMID 37870973

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[434]